Safe distance, safe patients! Therapeutic management of oncological patients affected by cutaneous and mucosal adverse events during the COVID-19 pandemic: an Italian experience
Sign Up to like & getrecommendations! Published in 2020 at "Supportive Care in Cancer"
DOI: 10.1007/s00520-020-05563-1
Abstract: Stringent measures have been taken to contain COVID-19 spread, limiting access only for urgent visits, surgery procedures, or hospitalizations and using teledermatology services for non-urgent cases. Management of oncological patients affected by chemo-, immune-, and… read more here.
Keywords: oncological patients; mucosal adverse; cutaneous mucosal; management oncological ... See more keywords
Surgical management and oncological follow‐up of cutaneous squamous cell carcinomas arising in epidermolysis bullosa patients
Sign Up to like & getrecommendations! Published in 2022 at "International Journal of Dermatology"
DOI: 10.1111/ijd.16157
Abstract: Hereditary epidermolysis bullosa (EB) is a rare genodermatosis characterized by skin fragility and blistering of the skin and mucous membranes in reaction to minimal traumas. The development of cutaneous squamous cell carcinomas (cSCCs) is one… read more here.
Keywords: cutaneous squamous; squamous cell; epidermolysis bullosa; management oncological ... See more keywords
Optimizing management of the oncological patient with pulmonary embolism: Validation of the epiphany index—PERSEO study.
Sign Up to like & getrecommendations! Published in 2020 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2020.38.15_suppl.12085
Abstract: 12085Background: EPIPHANY is the first algorithm to predict serious complications in both suspected and unsuspected cancer-associated pulmonary embolism (PE), overcoming limitations of previous mod... read more here.
Keywords: optimizing management; pulmonary embolism; management oncological; oncological patient ... See more keywords